Classification and treatment of XXXX .

@entity3347 @entity1 @entity1775 @entity8527 @entity935 @entity2045 @entity2515 @entity910 @entity914 @entity400 @entity2146 @entity716 @entity1773 @entity1950 @entity717 @entity3519
BACKGROUND: @entity910 are a group of delayed-onset @entity910 induced by a @entity935 receptor blocking agent. There are several phenomenologically distinct types of @entity1950 . REVIEW SUMMARY: The term @entity910 has been used to refer to the @entity1950 that presents with rapid, repetitive, stereotypic movements mostly involving the oral, buccal, and lingual areas. @entity3519 can be focal, segmental, or generalized. It commonly affects the face and neck followed by the arms and trunk. It usually results in retrocollis when it involves the neck and trunk arching backwards when it involves the trunk. Tardive @entity2146 is characterized by a feeling of inner @entity2146 and jitteriness with an inability to sit or stand still. Other @entity910 include @entity1775 , @entity2045 , @entity400 , and @entity3347 . It remains unclear whether @entity717 truly exists. The only way to prevent @entity1950 is to avoid its etiologic agents. Chronic use of @entity935 receptor blocking agents should be limited as much as possible to @entity1 with chronic @entity914 . In general, for mild @entity1950 , reducing the neuroleptic dose, switching to an atypical agent, or discontinuing antipsychotic treatment altogether in the hope of facilitating remission is recommended. For moderate to severe @entity1950 , @entity1773 or @entity2515 may be the most effective agent. Neuroleptics should be resumed to treat @entity8527 in the absence of active @entity716 only as a last resort for persistent, disabling, and treatment-resistant @entity8527 . CONCLUSIONS: The severity of the @entity1950 and the absolute need for antipsychotic therapy often dictate the treatment approach for this disorder.
